Search results for: 'research area pi3k akt signaling gsk'
-
A8169 Everolimus (RAD001)8 CitationTarget: mTORSummary: MTOR inhibitor
-
A5072 GSK690693Target: Akt|PKC|PKG|PKA|PrkSummary: Pan-AKT inhibitor,ATP-competitive and potent
-
A3724 PI-103 HydrochlorideTarget: PI3K|mTOR|DNA-PKSummary: DNA-PK/PI 3-kinase/mTOR inhibitor
-
B7543 GSK 789472 hydrochlorideSummary: dopamine D3 receptor antagonist and D2 partial agonist
-
B7752 GSK 1562590 hydrochlorideSummary: urotensin II (UT) receptor antagonist
-
A8214 AZD80552 CitationTarget: mTORSummary: MTOR inhibitor
-
A2681 TGX-221Target: PI3KSummary: PI3Kβ inhibitor,potent,selective and ATP competitive
-
A3005 CAL-101 (Idelalisib, GS-1101)2 CitationTarget: PI3KSummary: PI3K inhibitor
-
A2754 TG100-115Target: PI3KSummary: PI3Kγ/PI3Kδ inhibitor
-
A3238 BEZ235 Tosylate1 CitationSummary: MTOR/P13K inhibitor